Ya-Ting Hsu

Title: Innovations of Ya-Ting Hsu in Bioelectric Neuromodulation

Introduction

Ya-Ting Hsu is an accomplished inventor based in Kaohsiung, Taiwan. She has made significant contributions to the field of bioelectric neuromodulation, particularly in the context of enhancing hematopoiesis during chemotherapy treatments. Her innovative approach combines technology with medical applications, showcasing her dedication to improving patient outcomes.

Latest Patents

Ya-Ting Hsu holds a patent titled "Bioelectric neuromodulation for hematopoiesis regulation during chemotherapy." This invention involves a device and method designed to stimulate sympathetic nerves, thereby mitigating the negative impacts on hematopoiesis. The system includes an autonomic nerve actuator and stimulator, equipped with a graphic user interface (GUI) and a controller circuit. This circuit converts treatment parameters into a series of Building Block Waveforms (BBW), which are then output to Current/Voltage Driver Circuitry (CDC). The electrical stimulus outputs are coupled to electrodes positioned near specific nerve locations. The combination of this technology with conventional chemotherapy, such as carboplatin, has shown to significantly enhance hematopoiesis, improving white and red blood cell counts, platelet concentration, and hemoglobin levels, ultimately increasing survival rates in tested experimental groups.

Career Highlights

Throughout her career, Ya-Ting Hsu has worked with prestigious institutions, including National Cheng-Kung University and the University of California. Her work has been pivotal in advancing the understanding and application of bioelectric neuromodulation in medical treatments.

Collaborations

Ya-Ting has collaborated with notable colleagues, including Li-Hsien Chen and Wentai Liu. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Ya-Ting Hsu's contributions to bioelectric neuromodulation represent a significant advancement in medical technology, particularly in enhancing the efficacy of chemotherapy treatments. Her work continues to inspire future innovations in the field.